US/UK/Canada

Share

Quotes

With more than 300,000 deaths over the last eight years, substance abuse has been killing more people than any war.
Dr. Sanjay Gupta, President American Pain Association
Education and compassion are essential to achieving global acceptance of and access to cannabis.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"...may we reflect on how far we have come and continue to work toward the common goal of global cannabis access"
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"The goal of these new advances in cannabis-based medicine – and the reintroduction of cannabis in healthcare – is to leave an indelible mark on the healthcare industry."
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
It is clear that cannabis has reached the tipping point in the minds of the U.S. population.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
“It is clear that cannabis has reached the tipping point in the minds of the U.S. population.”
Dr. Stuart Titus, CEO - Medical Marijuana, Inc.
Pick a time period -
Tags ( Active)

Medical Marijuana, Inc.’s Year in Review: 2016 Vote for Cannabis Reform in 8 States, International Expansion Highlight Historic Year

Company Releases Recap Report of Activities in 2016 and Announces Excitement for Coming YearMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced the release of a 2016 business year in review posted to their website HERE . As you can view HERE , Medical Marijuana, Inc., has long been “A Company of First”. 2016 continued to show the company’s progress

MEDICAL MARIJUANA, INC.’S HEMPMEDS® MEXICO TO HOLD FIRST-EVER NATIONAL SYMPOSIUM ON MEDICAL CANNABIS FOR HEALTH PROFESSIONALS

Company Strengthens Industry Leadership Through Educating Medical Community on Therapeutic Uses of Cannabis for Treating Neurodegenerative DiseasesMedical Marijuana, Inc.  (OTC: MJNA) today announced that its subsidiary HempMeds® Mexico  will hold the first-ever symposium dedicated to providing the medical community with information about the medical value of cannabidiol (CBD) derivatives in the treatment of neurodegenerative diseases. The First National Symposium on Medical Cannabis, which will take place on Oct. 8 in Mexico City, is

MEDICAL MARIJUANA, INC.’S SUBSIDIARY HEMPMEDS® MEXICO TO SPONSOR AND EXHIBIT AT EXPOWEED CONFERENCE IN MEXICO CITY

First-Ever Cannabis Product Approved for Import Into Mexico, RSHO-X™, On Display as Mexico Families Advocate for Medical Cannabis in MexicoMedical Marijuana, Inc.  (OTC: MJNA) announced today that its subsidiary HempMeds® Mexico  is sponsoring and exhibiting at the Aug. 12-14 ExpoWeed Conference , the first-ever cannabis conference to be held in Mexico. In addition, on Aug. 14 at 10:15 a.m. HempMeds® Mexico ’s new president Dion Markgraaff will be speaking at the  ExpoWeed

MEDICAL MARIJUANA, INC. APPOINTS NEW PRESIDENT FOR ITS SUBSIDIARY HEMPMEDS® MEXICO AS DEMAND FOR ITS ZERO-THC CBD HEMP OIL INCREASES ACROSS COUNTRY

Cannabis Industry Veteran Dion Markgraaff to Take Helm of HempMeds® Mexico and Distribution of RSHO-X™, First-Ever Federally Approved Cannabidiol Product in MexicoMedical Marijuana, Inc.’s (OTC: MJNA) management team today announced that it has named Dion Markgraaff as President of its subsidiary HempMeds® Mexico , effective August 3, 2016. With more than 25 years of experience in the cannabis industry, Mr. Markgraaff will help drive the sales, marketing and distribution of HempMeds® Mexico 's non-psychoactive, THC-free hemp-based cannabidiol (

MEDICAL CANNABIS ACTIVIST RAUL ELIZALDE TO JOIN MEDICAL MARIJUANA, INC. AT SOUTHERN CALIFORNIA CANNABIS CONFERENCE AND EXPO

First-Ever Cannabis Product Approved for Import Into Mexico, RSHO-X™, Made in San Diego on Display as Elizalde Advocates for Medical Cannabis in MexicoMedical Marijuana, Inc.  (OTC: MJNA) announced today that medical cannabis activist Raul Elizalde of Mexico will join Company representatives at the Southern California Cannabis Conference and Expo  (SocalCCExpo) at the San Diego Convention Center to discuss his fight to unify the voices of families and patients in need of medical cannabis in Mexico. Raul Elizalde and his family

CNS News Reports Medical Marijuana Inc. Product RSHO-X™ First-Ever Approved as Import Into Mexico for Epilepsy Into “$10-12 Billion” Market

Medical Marijuana, Inc. Congratulates Mexico’s President Nieto for April 21 Speech, Which Came After Permits Issued for RSHO-X™ as First-Ever Cannabis Product Approved for Import Into MexicoSAN DIEGO, CA – April 25, 2016 – Medical Marijuana, Inc.  (OTC: MJNA) is proud to announce to shareholders and the public that in an April 22 article entitled Mexican President Reverses Course, Now Supports Medicinal Marijuana, CNSNews.com reported 

Medical Marijuana, Inc. Applauds Mexico’s President for Including RSHO-X™ Advocate Raul Elizalde in Speech About Findings of National Marijuana Debate

Series of National Debates in Mexico Sponsored by Medical Marijuana, Inc. and Historic Approval for RSHO-X™ as the First-Ever Legal Cannabis Product for Import Helped Lead to Historic ChangeApril 22, 2016 – One person can make a difference. Unifying the voices of families and patients in need of non-psychoactive cannabidiol (CBD) hemp oil access in Mexico is dedicated and loving father of Grace: Raul Elizalde. On Thursday, April 21, Elizalde joined Mexico’s President Enrique Peña Nieto at a conference 

There are no items matching the current filter
There are no more items matching the current filter
Back to top